Tesla Motors Inc (TSLA)’s 10 Biggest Hedge Fund Backers
In the latest round of 13F filings, Philippe Laffont's Coatue Management was the largest Tesla Motors Inc (NASDAQ:TSLA) shareholder, reporting a $76.2 million stake, which contains...
Posts Tagged ‘Daniel Gold QVT Financial’
Hedge Funds Have Bought WebMD Health Corp. (WBMD), VIVUS, Inc. (VVUS), and More
The most comprehensive look at hedge fund activity comes in the form of quarterly 13F filings, which disclose many of a fund’s positions as of the end of the quarter.
Should You Buy InterMune Inc (ITMN)?
In the 21st century investor’s toolkit, there are plenty of methods investors can use to analyze stocks. Two of the most useful are hedge fund and insider trading interest.
Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?
If you'd ask most shareholders, hedge funds are seen as slow, old investment vehicles of the past.
Do Hedge Funds and Insiders Love Clovis Oncology Inc (CLVS)?
Clovis Oncology Inc (NASDAQ:CLVS) was in 11 hedge funds' portfolio at the end of the first quarter of 2013. CLVS has seen an increase in hedge fund interest of late.
Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)
In today’s marketplace, there are many gauges investors can use to track publicly traded companies. A couple of the best are hedge fund and insider trading sentiment.
Hedge Funds Are Selling VIVUS, Inc. (VVUS)
Is VIVUS, Inc. (NASDAQ:VVUS) a good investment today? Money managers are in a pessimistic mood.
Arena Pharmaceuticals, Inc. (ARNA): One Mind-Blowing Metric Screaming ‘Buy’
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) an exceptional investment now? Prominent investors are taking a bullish view.
Peregrine Semiconductor Corp (PSMI): Are Hedge Funds Right About This Stock?
Peregrine Semiconductor Corp (NASDAQ:PSMI) was in 6 hedge funds' portfolio at the end of the fourth quarter of 2012.
Do Hedge Funds and Insiders Love Arena Pharmaceuticals, Inc. (ARNA)?: Charles River Laboratories (CRL), Synageva BioPharma Corp (GEVA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 11 hedge funds' portfolio at the end of the fourth quarter of 2012.
This Metric Says You Are Smart to Buy Anacor Pharmaceuticals Inc (ANAC): BioTime, Inc. (BTX), Coronado Biosciences Inc (CNDO)
Is Anacor Pharmaceuticals Inc (NASDAQ:ANAC) a sound investment now? Prominent investors are taking a bullish view.
Here is What Hedge Funds Think About Scorpio Tankers Inc. (STNG): Navios Maritime Partners L.P. (NMM), Diana Shipping Inc. (DSX)
In the financial world, there are dozens of indicators investors can use to track the equity markets. A duo of the most innovative are hedge fund and insider trading interest.
InterMune Inc (NASDAQ:ITMN): Insiders Are Dumping, Should You?
InterMune Inc (NASDAQ:ITMN) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012. ITMN has seen a decrease in hedge fund interest of late.
Do Hedge Funds and Insiders Love Rowan Companies PLC (NYSE:RDC)?
In the 21st century investor’s toolkit, there are plenty of methods investors can use to watch publicly traded companies.
Baker Brothers Reports Stakes in InterMune and Repros Therapeutics
Baker Brothers, a healthcare focused hedge fund managed by Julian and Felix Baker, has recently filed with the SEC to disclose significant percentage stakes in two development...
Which Hedge Fund is Animating Achillion?
QVT Financial, a hedge fund managed by Daniel Gold, specializes in healthcare-related stocks, holding about half of its equity portfolio in biotech and pharmaceutical stocks.
Best Hedge Fund Managers of 2011
Who are the best hedge fund managers of 2011? It usually isn't easy to define what best is. It isn't very difficult when it comes to hedge funds.
David Einhorn, George Soros At Davos, Warren Buffett’s Secretary
The following day, a corporate broker from Firm X and Punch management had a 45-minute conference call with Einhorn, during which inside information was disclosed to him, the ...
Bill Ackman, Phil Falcone’s LightSquared, Hedge Funds and Greece
Canadian Pacific Railway Ltd (CP) said William Ackman's hedge fund Pershing Square Capital Management has asked to elect five of its nominees to the company's board as the proxy...
Hedge Fund Redemption Falls, Top Stocks Picked By Investment Banks, Buffett Blames For Romney’s Tax Rate, Etc…
Redemption requests by hedge fund clients have fallen to the lowest monthly level on record as improving market sentiment combined with a typical seasonal lull in asset re-allocation...
Ackman Plans A Proxy Fight, Todd Combs Posted Gain In Bershire, Chase Coleman Returned 45% In 2011
William Ackman’s plan to wage a proxy fight to install a new chief executive officer at Canadian Pacific Railway Ltd.
Daniel Gold’s QVT Financial Raised Stake In $OREX
Daniel Gold’s QVT Financial discloses that it now has 5.29 million shares in Orexigen Therapeutics, Inc. (OREX), corresponding to a 9.82% passive stake.
D. E. Shaw Loses Big After InterMune Drops 18%
InterMune Inc. (ITMN) drops 18.64% at 2:05PM EST today.
Hedge Funds Make Big After Regeneron $REGN Gets FDA OK for Eylea
Regeneron Pharmaceuticals Inc.'s (REGN) shares rose 13.73% in trading on Monday after U.S.
Hedge Funds Make a Bundle on Dynegy $DYN
Dynegy Inc (DYN) shares shot up 26.10% in trading on Tuesday. The increase came after reports that "Dynegy Inc.'s holding company filed for Chapter 11 bankruptcy protection in...
Hedge Funds Make a Bundle on Inhibitex $INHX
Shares of Inhibitex (INHX) more than doubled Friday morning.
Insider Trading: Daniel Gold’s QVT Financial Sold 650 Thousand Shares in $ANDS
Daniel Gold’s QVT Financial sold 650 thousand shares in Anadys Pharmaceuticals Inc. (ANDS) on October 17th. According to the firm’s Form 4 and amend 13D on October 19th.
Steven Cohen’s SAC Capital Increased Its Position in $ITMN
Steven Cohen’s SAC Capital declared on October 14th that the firm has increased its passive stock position in Intermune Inc.
Hedge Fund Winners in FDA Panel’s Regeneron Decision $REGN
A new eye medicine from Regeneron Pharmaceuticals (REGN) and Bayer AG was a safe and effective way of treating vision loss from macular degeneration, a U.S.
Alydar Capital Boosts Its Asbury Automotive Group Bet $ABG
John Murphy's Alydar Capital disclosed a 5.02% stake in Asbury Automotive Group (ABG) yesterday. Alydar Capital had 625K shares of ABG in its portfolio at the end of March.
